Dr. Michal Konštacký is a physician, scientist, and innovator with global experience in clinical medicine, pharma, and health-tech. Specializing in internal medicine, he focuses on longevity and personalized healthcare.

He has held leadership roles in major pharmaceutical companies across Switzerland, Spain, Sweden, and the UK, driving innovation in rare metabolic diseases, neurology, and oncology. He also served as a medical educator and advisor to Czech ministries and the Academy of Sciences.

Educated at Charles University (MUDr., PhD) and City University of Seattle (MBA), Dr. Konštacký has further training from Harvard, MIT, and Salford University in psychotherapy, AI in healthcare, negotiation, and business law.

Now based in Zurich, he continues to lead health innovation projects and is the author of three books and hundreds of publications.